SCHEMBL6841232

SCHEMBL6841232

O=C(CCN1CCCCC1)c1ccc2oc3ccc(C(=O)CCN4CCCCC4)cc3c(=O)c2c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.57
MAOB P27338 5/20 0.57
HPGD P15428 3/20 0.57
MAPT P10636 3/20 0.56
HSD17B10 Q99714 2/20 0.56
KMT2A Q03164 5/20 0.54
GFER P55789 1/20 0.52
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
HTT P42858 1/20 0.50
TP53 P04637 1/20 0.49
TSHR P16473 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HRH3 Q9Y5N1 4/20 0.48
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11748405 0.92 MAOB (0.52) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL11751257 0.91 KDM4E (0.55) ALDH1A1MAOBHPGDL3MBTL1HRH3
SCHEMBL11551512 0.86 KDM4E (0.54) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL11551105 0.85 KDM4E (0.59) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL11552125 0.85 ALDH1A1 (0.52) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL6843675 0.83 HTR1A (0.54) ALDH1A1MAPTKMT2AMEN1POLB
Hydrochloric Acid SCHEMBL11551776 0.81 ALDH1A1 (0.50) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL11551316 0.80 ALPL (0.61) ALDH1A1MAOBHPGDMAPTHSD17B10
SCHEMBL11795192 0.79 CYP2D6 (0.60) MAOBKMT2AMEN1HRH3BCHE
Hydrochloric Acid SCHEMBL29794111 0.79 ALPL (0.64) ALDH1A1MAOBHPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063785-A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use GUILFORD PHARMACEUTICALS, INC. 2004-04-01 US disclosed
EP-1360167-A1 SYMMETRICALLY DISUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING POLY (ADP-RIBOSE) GLYCOHYDROLASE, AND METHODS FOR THEIR USE GUILFORD PHARMACEUTICALS INC. (US) 2003-11-12 EP disclosed
US-6635786-B2 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use GUILFORD PHARMACEUTICALS, INC. 2003-10-21 US disclosed
US-20020132852-A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use GUILFORD PHARMACEUTICALS, INC. 2002-09-19 US disclosed
WO-2002057211-A1 SYMMETRICALLY DISUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING POLY (ADP-RIBOSE) GLYCOHYDROLASE, AND METHODS FOR THEIR USE GUILFORD PHARMACEUTICALS, INC. (US) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063785-A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use PARG, PARP1, PARP11 ALDH1A1 916/4885MAOB 91/4885HPGD 120/4885
US-20020132852-A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use PARG, PARP1, PARP11 ALDH1A1 916/4885MAOB 91/4885HPGD 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.